A Cohort Study on Anti-microbial Stewardship in PICU
Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · May 8, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve the use of antibiotics in the Pediatric Intensive Care Unit (PICU) for children with infections. The goal is to ensure that patients receive the right antibiotics at the right time, which can help them recover faster and reduce the risk of complications, such as longer hospital stays or infections that are harder to treat. The trial will look into different strategies, like checking patients’ medical history, taking the right samples for testing, and adjusting treatments based on daily evaluations by healthcare teams.
To participate in this study, children must be admitted to the ICU for more than 48 hours. Unfortunately, those who are in the ICU for less than 48 hours won’t be eligible. Participants can expect to be part of a team effort that focuses on effective antibiotic use, which may improve their treatment outcomes. This trial is not yet recruiting patients, but it aims to gather valuable information that could help in managing infections more effectively in critically ill children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted to the ICU for more than 48 hour
- Exclusion Criteria:
- • Patients admitted to ICU less than 48 hours
About Children's Hospital Of Fudan University
The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported